Cas 1027285-23-9,3-(3-cyano-phenyl)-5-tetrazol-2-ylmethyl-4,5-dihydro-isoxazole-5-carboxylic acid (2'-<i>tert</i>-butylsulfamoyl-biphenyl-4-yl)-amide

1027285-23-9

Post Buying Request

Basic information

Product Name: 3-(3-cyano-phenyl)-5-tetrazol-2-ylmethyl-4,5-dihydro-isoxazole-5-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide
Synonyms:
CAS NO:1027285-23-9
Molecular Formula:
Molecular Weight: 584.659
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-(3-cyano-phenyl)-5-tetrazol-2-ylmethyl-4,5-dihydro-isoxazole-5-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide(CAS DataBase Reference)
NIST Chemistry Reference: 3-(3-cyano-phenyl)-5-tetrazol-2-ylmethyl-4,5-dihydro-isoxazole-5-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide(1027285-23-9)
EPA Substance Registry System: 3-(3-cyano-phenyl)-5-tetrazol-2-ylmethyl-4,5-dihydro-isoxazole-5-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide(1027285-23-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1027285-23-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1027285-23-9 Suppliers

Recommended suppliers

1027285-23-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1027285-23-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,7,2,8 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1027285-23:
(9*1)+(8*0)+(7*2)+(6*7)+(5*2)+(4*8)+(3*5)+(2*2)+(1*3)=129
129 % 10 = 9
So 1027285-23-9 is a valid CAS Registry Number.

1027285-23-9Upstream product

1027285-23-9Downstream Products

1027285-23-9Relevant academic research and scientific papers

Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 2

Quan, Mimi L.,Ellis, Christopher D.,Liauw, Ann Y.,Alexander, Richard S.,Knabb, Robert M.,Lam, Gilbert,Wright, Matthew R.,Wong, Pancras C.,Wexler, Ruth R.

, p. 2760 - 2773 (2007/10/03)

Intravascular clot formation is an important factor in a number of cardiovascular diseases. Therefore, the prevention of blood coagulation has become a major target for new therapeutic agents. One attractive approach is the inhibition of factor Xa (FXa),

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1027285-23-9